Abstract: Embodiments of the present invention provide a method for sharing an application between terminals. The method includes: generating, by a first terminal according to an application that has been installed, a shared application installation package of the application; sending, by the first terminal, the shared application installation package to a second terminal; determining, by the first terminal, shared data of the application that has been installed, where the shared data is data that is from an application server and required for the application to run; and sending, by the first terminal, the shared data to the second terminal. In the embodiments of the present invention, when sharing an application, two terminals not only share an installation package of the application, but also share shared data of the application.

Abstract: The present disclosure provides an anti-tumor polypeptide Bax-BH3, a fluorescent polymeric nanomicelle, a preparation method and use thereof, belonging to the technical field of medicines. The anti-tumor polypeptide Bax-BH3 has an amino acid sequence set forth in SEQ ID No: 1; the fluorescent polymeric nanomicelle includes the anti-tumor polypeptide Bax-BH3 and a polymer carrier; and the polymer carrier is a block copolymer RGD-PHPMA-b-Poly(MMA-alt-(Rhob-MA)). In the present disclosure, the anti-tumor polypeptide Bax-BH3 has desirable biocompatibility and biological activity; and the fluorescent polymeric nanomicelle encapsulates the anti-tumor polypeptide Bax-BH3 by the block copolymer RGD-PHPMA-b-Poly(MMA-alt-(Rhob-MA)), with high encapsulation rate and drug loading, and good release performance.

Abstract: Disclosed herein is a module for supporting a device configured to manipulate charged particle paths in a charged particle apparatus, the module comprising: a support arrangement configured to support the device, wherein the device is configured to manipulate a charged particle path within the charged particle apparatus; and a support positioning system configured to move the support arrangement within the module; wherein the module is arranged to be field replaceable in the charged particle apparatus.

Abstract: The present disclosure provides a method for testing an internal force increment of an arch bridge suspender by inertial measurement, including the following steps: (1) selecting a suspender to be tested with internal force increment, and mounting an acceleration sensing device or a speed sensing device at a lower edge of the suspender to be tested; (2) setting an appropriate sampling frequency and collecting signals; (3) processing information data collected in step (2) by using Formulas; and (4) recording a result of the information data processing and obtaining the internal force increment of the suspender. The method can obtain the internal force increment of the suspender by collecting acceleration or speed signals of the lower edge of the suspender and performing calculation from the signals. This method has the advantages of simple and convenient testing, high replicability and low test cost.

Abstract: Disclosed are a polyethylene glycol conjugate drug, and a preparation method therefor and the use thereof. Specifically, the present invention relates to a polyethylene glycol conjugate drug represented by formula A or a pharmaceutically acceptable salt thereof, a method for preparing the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof, an intermediate for preparing the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof, and the use of the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof in the preparation of a drug.

Abstract: The present invention provides a method for preparing a gallium oxide semiconductor structure and a gallium oxide semiconductor structure obtained thereby.

Abstract: The present invention relates to a sunscreen cosmetic for application to a user's skin. The sunscreen cosmetic is provided with a mineral including zinc oxide, titanium dioxide, or a combination of both. The sunscreen cosmetic also includes a high buffering-capacity agent configured to react with an external acidic source coming in contact with the cosmetic and to inhibit release of zinc ions from the zinc oxide and/or to inhibit release of titanium ions from the titanium dioxide.

Abstract: A first device is logged in with a first user account. The first device displays an avatar of a second user account in a first user interface of the first device. In response to an interaction instruction triggered on the avatar of the second user account, the first device generates an interaction message according to a first field corresponding to the first user account, an action description field corresponding to the interaction instruction, and a second field corresponding to the second user account. The first device transmits the interaction message to a second device that is logged in with the second user account.

Abstract: Provided are method and system of calculating cross-section area and included angle of three-dimensional blood vessel branch, comprising: obtaining the contours of a main blood vessel and a branch blood vessel; determining connecting points of the main blood vessel and the branch blood vessel, a three-dimensional branch outer contour, and an initial normal vector of a branch section; determining the position of the branch section at the branch connecting part and an intersecting cross-section of the branch section and the branch outer contour; rotating the three-dimensional branch cross-section contour to obtain an equivalent two-dimensional branch cross-section contour, and calculating the area of the two-dimensional branch cross-section contour; obtaining branch cross-section areas and corresponding normal vectors thereof; and taking the minimum branch cross-section area as the cross-section area of this segment of branch blood vessel, and determining the included angle between the branch blood vessel and t

Abstract: A method includes displaying a physiological parameter measurement interface comprising a plurality of physiological parameter identifiers, receiving a physiological parameter measurement operation, wherein the physiological parameter measurement operation comprises an operation of selecting, among the physiological parameter identifiers, a first physiological parameter identifier and a second physiological parameter identifier; and measuring, in response to the physiological parameter measurement operation, a first physiological parameter and a second physiological parameter of a measured object using a physiological parameter sensor of the electronic device.

Abstract: Various embodiments relate to the field of communications technologies, and provide a light adjustment method and a terminal to resolve a problem that an existing light therapy device cannot flexibly adjust light based on a light requirement of a user and cannot more intelligently adjust a circadian rhythm of the user. In those embodiments, an awake time period and a sleep time period of a user is determined by the terminal, and parameter thresholds in the awake time period and the sleep time period is determined by the terminal. In those embodiments, a light parameter in a current time period is obtain by the terminal, and based on the light parameter in the current time period, a light parameter of light emitted by a light source device is then adjusted by the terminal.

Abstract: A method includes sending, by an application that is to obtain a verification code, a verification code obtaining request to a server, where the application that is to obtain a verification code is installed on a terminal, and where applications installed on the terminal further include an input method application and a short message service (SMS) message application; receiving, by the SMS message application, an SMS message that includes a verification code and that is sent by the server; and reading, by the input method application, the verification code in the SMS message, where the terminal does not allow an application other than the input method application and the SMS message application to read an SMS message in the terminal.

Abstract: The core active components of the present composition, termed as de-ironizing inducers (DII), has a reducing agent and a precipitating agent. Molar ratios of the reducing agent with the precipitating agent range from 1:3-6 and the core components in the skincare product range from 0.1% to 10% w/w. The pH value of the skincare product is between 6.6 and 7.4. The skin care products can safely and effectively 5 remove iron in the skin, which has been shown to accelerate the visible signs of aging. The core components can also be used in combination with conventional skincare product compounds to achieve better anti-aging effects.

Abstract: A flood risk prediction method includes: collecting basic meteorological hydrological data of a basin by using a data collection and storage box; calibrating a basin hydrological model and a machine learning model; obtaining a meteorological simulation series under M groups of climate change scenarios and driving the basin hydrological model and the machine learning model to simulate a basin hydrological process under a future scenario; establishing a water and heat coupling balance equation of the basin to obtain annual average underlying surface feature parameters of the basin; extracting feature values of a flood duration and a flood volume and with the feature parameters as co-variates, establishing a joint probability distribution function; obtaining a joint return period of the flood duration and the flood volume; based on a dataset of the shared socioeconomic pathway, deriving a social economic exposure degree of future flood risk increase.

Abstract: The present disclosure belongs to the biopharmaceutical field, and discloses uses of Trezastilbenoside in manufacture of a product for treating and/or preventing a disease of respiratory system, and particularly uses of Trezastilbenoside in manufacture of a product for treating and/or preventing a disease of respiratory system with symptoms of cough and/or expectoration and/or asthma. As indicated by the test results of the present disclosure, Trezastilbenoside has significant efficacy of relieving cough, eliminating phlegm, relieving asthma and anti-inflammation, and has a potential therapeutic effect on respiratory system diseases, thus possessing broad prospects in clinical application.

Abstract: Embodiments of the present invention provide a method for sharing an application between terminals. The method includes: generating, by a first terminal according to an application that has been installed, a shared application installation package of the application; sending, by the first terminal, the shared application installation package to a second terminal; determining, by the first terminal, shared data of the application that has been installed, where the shared data is data that is from an application server and required for the application to run; and sending, by the first terminal, the shared data to the second terminal. In the embodiments of the present invention, when sharing an application, two terminals not only share an installation package of the application, but also share shared data of the application.

Abstract: A network access method includes: establishing a BLUETOOTH connection to a BLUETOOTH terminal; receiving, using the BLUETOOTH connection, a network access request from the BLUETOOTH terminal; and when the BLUETOOTH terminal is an authorized device, activating a BLUETOOTH network sharing function automatically and forwarding the network access request to a wide area network.

Abstract: A method for enabling a task management interface includes receiving an instruction for enabling the task management interface, displaying the task management interface in response to the instruction for enabling the task management interface, where the task management interface includes a preview interface of at least one application program and an icon corresponding to at least one function of the application program, receiving an operation instruction for the icon, and switching the application program corresponding to the icon to a foreground and executing the function in response to the operation instruction.

Abstract: This application discloses a premature beat detection method, an electronic device. The premature beat detection method in this application includes: performing premature beat detection on a user by using a premature beat detection function; determining a premature beat type of the user by using a premature beat type determining function when detecting that the user has a premature beat by using the premature beat detection function, and calculating premature beat load of the user based on detection data obtained by the premature beat detection function; and reminding the user of a premature beat risk when the calculated premature beat load is greater than a premature beat load threshold corresponding to the premature beat type determined by the premature beat type determining function.